A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

计划入组 80 人 · 首次发布于 2026 年 1 月 6 日

Microsatellite Instability in Colorectal Cancers

计划入组 231 人 · 首次发布于 2021 年 12 月 17 日

National Cohort of Colorectal Cancers With Microsatellite Instability

计划入组 637 人 · 首次发布于 2022 年 8 月 23 日

antibody-based therapy (microsatellite-stable colorectal cancer)

Colorectal cancer vaccine (Oryx)

Colorectal Cancer(Envisagenics)

Austrian Breast & Colorectal Cancer Study Group

Austria

BORDEAUX COLORECTAL INSTITUTE ACADEMY

France

CENTER WEST CANCER

United States

FDA Approves IND and Grants Fast Track Designation for CBI-1214 T-Cell Engager in Colorectal Cancer

KAHR Bio's DSP107 Combination Shows Promise in Microsatellite Stable Colorectal Cancer at ASCO 2025

Larkspur Biosciences Unveils First-in-Class PIP4K2C Degrader LRK-4189 for Microsatellite Stable Colorectal Cancer